Concepts (178)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Urinary Bladder | 19 | 2021 | 108 | 4.920 |
Why?
|
| Tissue Scaffolds | 6 | 2018 | 111 | 1.760 |
Why?
|
| Tissue Engineering | 7 | 2018 | 212 | 1.570 |
Why?
|
| Urinary Bladder Neck Obstruction | 3 | 2021 | 12 | 1.500 |
Why?
|
| Urothelium | 4 | 2021 | 22 | 1.380 |
Why?
|
| Muscle, Smooth | 6 | 2009 | 117 | 1.340 |
Why?
|
| Myocytes, Smooth Muscle | 8 | 2018 | 144 | 1.310 |
Why?
|
| Hydrogels | 3 | 2018 | 54 | 1.140 |
Why?
|
| Rats, Sprague-Dawley | 22 | 2021 | 2083 | 1.090 |
Why?
|
| Adenosine Triphosphate | 2 | 2018 | 314 | 0.940 |
Why?
|
| Mechanotransduction, Cellular | 3 | 2010 | 27 | 0.930 |
Why?
|
| Urinary Bladder, Neurogenic | 3 | 2007 | 11 | 0.830 |
Why?
|
| Urination | 1 | 2021 | 19 | 0.810 |
Why?
|
| Rats | 22 | 2021 | 5300 | 0.810 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2021 | 135 | 0.740 |
Why?
|
| Receptors, Purinergic P2X4 | 1 | 2018 | 3 | 0.670 |
Why?
|
| Epithelial Cells | 1 | 2021 | 431 | 0.670 |
Why?
|
| Caspase 1 | 1 | 2018 | 22 | 0.660 |
Why?
|
| NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2018 | 22 | 0.660 |
Why?
|
| Collagen | 6 | 2014 | 636 | 0.660 |
Why?
|
| Extracellular Matrix | 2 | 2015 | 493 | 0.660 |
Why?
|
| Tissue Adhesives | 2 | 2018 | 17 | 0.650 |
Why?
|
| Inflammasomes | 1 | 2018 | 39 | 0.640 |
Why?
|
| Biocompatible Materials | 4 | 2018 | 247 | 0.600 |
Why?
|
| Spinal Cord Injuries | 5 | 2009 | 551 | 0.600 |
Why?
|
| Animals | 27 | 2021 | 20877 | 0.570 |
Why?
|
| Polyurethanes | 1 | 2015 | 21 | 0.540 |
Why?
|
| Coated Materials, Biocompatible | 1 | 2015 | 54 | 0.520 |
Why?
|
| Cells, Cultured | 9 | 2021 | 2673 | 0.520 |
Why?
|
| Ethylenediamines | 1 | 2014 | 5 | 0.520 |
Why?
|
| Particle Size | 1 | 2015 | 201 | 0.510 |
Why?
|
| Cyanoacrylates | 1 | 2014 | 8 | 0.480 |
Why?
|
| Hemostatic Techniques | 1 | 2014 | 23 | 0.480 |
Why?
|
| Stress, Mechanical | 9 | 2014 | 208 | 0.460 |
Why?
|
| Pressure | 4 | 2021 | 252 | 0.460 |
Why?
|
| Ion Channels | 2 | 2010 | 72 | 0.440 |
Why?
|
| Nanoparticles | 1 | 2015 | 254 | 0.420 |
Why?
|
| Osteoblasts | 2 | 2003 | 99 | 0.420 |
Why?
|
| Ion Channel Gating | 1 | 2010 | 42 | 0.380 |
Why?
|
| Diabetes Mellitus, Experimental | 2 | 2009 | 195 | 0.340 |
Why?
|
| Female | 19 | 2021 | 38015 | 0.340 |
Why?
|
| Tissue Culture Techniques | 1 | 2008 | 62 | 0.330 |
Why?
|
| Gene Expression Regulation | 4 | 2009 | 1293 | 0.310 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2007 | 222 | 0.280 |
Why?
|
| Cell Survival | 4 | 2018 | 901 | 0.280 |
Why?
|
| Hydrostatic Pressure | 3 | 2018 | 11 | 0.270 |
Why?
|
| Growth Substances | 1 | 2005 | 77 | 0.270 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2007 | 331 | 0.260 |
Why?
|
| Models, Biological | 3 | 2009 | 981 | 0.260 |
Why?
|
| Elastin | 2 | 2008 | 116 | 0.250 |
Why?
|
| Polymers | 2 | 2018 | 244 | 0.250 |
Why?
|
| DNA | 1 | 2007 | 597 | 0.250 |
Why?
|
| Materials Testing | 3 | 2014 | 263 | 0.250 |
Why?
|
| Cell Nucleus | 1 | 2005 | 305 | 0.240 |
Why?
|
| Osteocalcin | 1 | 2003 | 37 | 0.240 |
Why?
|
| Physical Stimulation | 1 | 2003 | 67 | 0.230 |
Why?
|
| Cell Line | 2 | 2018 | 1752 | 0.220 |
Why?
|
| Osteogenesis | 1 | 2003 | 152 | 0.210 |
Why?
|
| Fibrosis | 2 | 2021 | 371 | 0.190 |
Why?
|
| Transforming Growth Factor beta | 1 | 2003 | 384 | 0.190 |
Why?
|
| Biomechanical Phenomena | 3 | 2018 | 368 | 0.180 |
Why?
|
| Calcium | 1 | 2003 | 929 | 0.170 |
Why?
|
| Cell Proliferation | 3 | 2015 | 1173 | 0.170 |
Why?
|
| Purinergic P2X Receptor Antagonists | 1 | 2018 | 2 | 0.170 |
Why?
|
| Tissue Adhesions | 1 | 2018 | 21 | 0.170 |
Why?
|
| Polypropylenes | 1 | 2018 | 31 | 0.160 |
Why?
|
| Viscosity | 3 | 2009 | 72 | 0.160 |
Why?
|
| Surface Properties | 2 | 2018 | 363 | 0.160 |
Why?
|
| Elasticity | 3 | 2009 | 103 | 0.160 |
Why?
|
| Actins | 2 | 2009 | 249 | 0.150 |
Why?
|
| Cell Culture Techniques | 3 | 2010 | 189 | 0.150 |
Why?
|
| Enzyme Activation | 1 | 2018 | 791 | 0.140 |
Why?
|
| Cell Adhesion | 2 | 2015 | 324 | 0.140 |
Why?
|
| Gelatin | 1 | 2015 | 14 | 0.140 |
Why?
|
| Hot Temperature | 2 | 2014 | 152 | 0.130 |
Why?
|
| Fibronectins | 1 | 2015 | 130 | 0.130 |
Why?
|
| Elastic Modulus | 1 | 2014 | 25 | 0.130 |
Why?
|
| Acrylates | 1 | 2014 | 17 | 0.130 |
Why?
|
| Succinimides | 1 | 2014 | 11 | 0.130 |
Why?
|
| Shear Strength | 1 | 2014 | 15 | 0.130 |
Why?
|
| Adhesives | 1 | 2014 | 9 | 0.130 |
Why?
|
| Microscopy, Fluorescence | 1 | 2015 | 261 | 0.120 |
Why?
|
| Ultraviolet Rays | 1 | 2014 | 130 | 0.120 |
Why?
|
| Adaptation, Physiological | 2 | 2005 | 189 | 0.120 |
Why?
|
| Amines | 1 | 2014 | 98 | 0.120 |
Why?
|
| Thrombin | 1 | 2014 | 117 | 0.120 |
Why?
|
| Hyaluronic Acid | 1 | 2014 | 206 | 0.120 |
Why?
|
| Oligopeptides | 1 | 2014 | 152 | 0.110 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2014 | 346 | 0.110 |
Why?
|
| Drug Combinations | 1 | 2014 | 304 | 0.110 |
Why?
|
| Polyethylene Glycols | 1 | 2014 | 149 | 0.110 |
Why?
|
| Cell Movement | 1 | 2015 | 630 | 0.110 |
Why?
|
| Cell Count | 2 | 2010 | 248 | 0.100 |
Why?
|
| Hydrogel, Polyethylene Glycol Dimethacrylate | 1 | 2010 | 17 | 0.090 |
Why?
|
| Proteins | 1 | 2014 | 473 | 0.090 |
Why?
|
| Muscle Relaxation | 1 | 2009 | 31 | 0.090 |
Why?
|
| Signal Transduction | 1 | 2018 | 2688 | 0.080 |
Why?
|
| Angioplasty, Balloon | 1 | 2009 | 110 | 0.080 |
Why?
|
| Microtubules | 1 | 2009 | 104 | 0.080 |
Why?
|
| Muscle Contraction | 1 | 2008 | 210 | 0.080 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2009 | 317 | 0.080 |
Why?
|
| Chromones | 1 | 2007 | 33 | 0.080 |
Why?
|
| Androstadienes | 1 | 2007 | 41 | 0.080 |
Why?
|
| Morpholines | 1 | 2007 | 79 | 0.070 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2008 | 144 | 0.070 |
Why?
|
| Equipment Design | 2 | 2010 | 500 | 0.070 |
Why?
|
| Collagen Type I | 2 | 2003 | 175 | 0.070 |
Why?
|
| Matrix Metalloproteinase 1 | 1 | 2005 | 74 | 0.070 |
Why?
|
| Time Factors | 3 | 2009 | 4655 | 0.070 |
Why?
|
| Hypertrophy | 1 | 2005 | 89 | 0.070 |
Why?
|
| Reproducibility of Results | 2 | 2009 | 2077 | 0.070 |
Why?
|
| Gene Expression | 1 | 2008 | 770 | 0.070 |
Why?
|
| RNA, Messenger | 3 | 2004 | 1663 | 0.060 |
Why?
|
| Thermoreceptors | 1 | 2004 | 2 | 0.060 |
Why?
|
| Genitalia, Male | 1 | 2004 | 14 | 0.060 |
Why?
|
| Receptors, Drug | 1 | 2004 | 31 | 0.060 |
Why?
|
| Intestinal Mucosa | 1 | 2005 | 219 | 0.060 |
Why?
|
| Tensile Strength | 1 | 2004 | 90 | 0.060 |
Why?
|
| Anisotropy | 1 | 2004 | 105 | 0.060 |
Why?
|
| Thoracic Vertebrae | 1 | 2004 | 52 | 0.060 |
Why?
|
| Phosphorylation | 1 | 2007 | 1199 | 0.060 |
Why?
|
| Cell Differentiation | 1 | 2008 | 1034 | 0.060 |
Why?
|
| Enzyme Inhibitors | 1 | 2007 | 659 | 0.060 |
Why?
|
| Periodicity | 1 | 2003 | 43 | 0.060 |
Why?
|
| Gene Expression Profiling | 1 | 2005 | 498 | 0.060 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2003 | 126 | 0.060 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-1 | 1 | 2002 | 59 | 0.060 |
Why?
|
| Inflammation | 1 | 2009 | 1030 | 0.060 |
Why?
|
| Animals, Newborn | 1 | 2003 | 396 | 0.050 |
Why?
|
| Apoptosis | 1 | 2009 | 1640 | 0.050 |
Why?
|
| Neoplasm Proteins | 1 | 2004 | 307 | 0.050 |
Why?
|
| Bone Development | 1 | 2001 | 37 | 0.050 |
Why?
|
| Humans | 5 | 2018 | 68525 | 0.050 |
Why?
|
| Matrix Metalloproteinases | 1 | 2002 | 223 | 0.050 |
Why?
|
| Bone and Bones | 1 | 2001 | 145 | 0.050 |
Why?
|
| Computer Simulation | 1 | 2004 | 705 | 0.050 |
Why?
|
| Cell Division | 1 | 2001 | 541 | 0.050 |
Why?
|
| Serum Albumin, Human | 1 | 2018 | 10 | 0.040 |
Why?
|
| Serum Albumin, Bovine | 1 | 2018 | 43 | 0.040 |
Why?
|
| Surgical Mesh | 1 | 2018 | 57 | 0.040 |
Why?
|
| Compliance | 2 | 2005 | 26 | 0.030 |
Why?
|
| Cell Growth Processes | 1 | 2010 | 40 | 0.020 |
Why?
|
| Regenerative Medicine | 1 | 2010 | 17 | 0.020 |
Why?
|
| Histocytochemistry | 1 | 2010 | 149 | 0.020 |
Why?
|
| Microcirculation | 1 | 2010 | 77 | 0.020 |
Why?
|
| Vimentin | 1 | 2009 | 47 | 0.020 |
Why?
|
| Cell Size | 1 | 2009 | 76 | 0.020 |
Why?
|
| Hyperplasia | 1 | 2009 | 89 | 0.020 |
Why?
|
| Cytochalasin D | 1 | 2009 | 10 | 0.020 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2009 | 160 | 0.020 |
Why?
|
| Nocodazole | 1 | 2009 | 11 | 0.020 |
Why?
|
| Tubulin Modulators | 1 | 2009 | 10 | 0.020 |
Why?
|
| Muscle Proteins | 1 | 2009 | 94 | 0.020 |
Why?
|
| Depsipeptides | 1 | 2009 | 21 | 0.020 |
Why?
|
| Regeneration | 1 | 2010 | 105 | 0.020 |
Why?
|
| Constriction, Pathologic | 1 | 2009 | 236 | 0.020 |
Why?
|
| Paclitaxel | 1 | 2009 | 140 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2009 | 320 | 0.020 |
Why?
|
| Computational Biology | 1 | 2009 | 190 | 0.020 |
Why?
|
| Aorta | 1 | 2009 | 316 | 0.020 |
Why?
|
| Linear Models | 1 | 2009 | 521 | 0.020 |
Why?
|
| Endothelium, Vascular | 1 | 2009 | 371 | 0.020 |
Why?
|
| Phenotype | 1 | 2009 | 946 | 0.020 |
Why?
|
| Clone Cells | 1 | 2005 | 67 | 0.020 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2005 | 236 | 0.020 |
Why?
|
| Intestine, Small | 1 | 2005 | 89 | 0.020 |
Why?
|
| TRPM Cation Channels | 1 | 2004 | 5 | 0.020 |
Why?
|
| Cold Temperature | 1 | 2004 | 90 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2004 | 282 | 0.020 |
Why?
|
| Stem Cells | 1 | 2005 | 248 | 0.020 |
Why?
|
| Biomarkers | 1 | 2009 | 1593 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2005 | 682 | 0.010 |
Why?
|
| Collagen Type III | 1 | 2002 | 21 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2004 | 710 | 0.010 |
Why?
|
| Muscle, Skeletal | 1 | 2005 | 396 | 0.010 |
Why?
|
| In Vitro Techniques | 1 | 2002 | 765 | 0.010 |
Why?
|
| Male | 3 | 2009 | 37281 | 0.010 |
Why?
|
| Mice | 1 | 2005 | 8472 | 0.010 |
Why?
|